• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮与气道疾病

Nitric oxide and airway disease.

作者信息

Barnes P J

机构信息

Department of Thoracic Medicine, National Heart and Lung Institute, London, UK.

出版信息

Ann Med. 1995 Jun;27(3):389-93. doi: 10.3109/07853899509002592.

DOI:10.3109/07853899509002592
PMID:7546629
Abstract

Nitric oxide (NO) may play an important role in regulating airway function and in the pathophysiology of inflammatory airway diseases. Endothelium-derived NO may be important in regulating airway blood flow and, indirectly, plasma exudation. NO is the neurotransmitter of bronchodilator nerves in human airways and counteracts the bronchoconstriction due to cholinergic neural mechanisms. Inducible NO synthase (iNOS) is expressed in human epithelial cells in response to pro-inflammatory cytokines and oxidants, probably via activation of the transcription factor nuclear factor kappa B (NF-kappa B). There is increased expression of iNOS in the epithelium of asthmatic patients and in lung macrophages in bronchiectasis. This may account for the increased concentration of NO in the exhaled air of patients with inflammatory airways disease. Increased NO production in the airways may result in hyperaemia, plasma exudation, mucus secretion and indirectly increased proliferation of Th2 lymphocytes responsible for eosinophilic inflammation. Glucocorticoids inhibit the induction of iNOS in epithelial cells and reduce the elevated exhaled NO to normal values. Selective inhibitors of iNOS may be useful in the treatment of inflammatory airway diseases, such as asthma, in the future.

摘要

一氧化氮(NO)可能在调节气道功能以及炎性气道疾病的病理生理学过程中发挥重要作用。内皮源性NO可能在调节气道血流以及间接调节血浆渗出方面具有重要作用。NO是人类气道中舒张支气管神经的神经递质,可对抗胆碱能神经机制引起的支气管收缩。诱导型一氧化氮合酶(iNOS)在人类上皮细胞中响应促炎细胞因子和氧化剂而表达,可能是通过激活转录因子核因子κB(NF-κB)实现的。哮喘患者的上皮以及支气管扩张症患者的肺巨噬细胞中iNOS表达增加。这可能解释了炎性气道疾病患者呼出气中NO浓度升高的原因。气道中NO生成增加可能导致充血、血浆渗出、黏液分泌,并间接导致负责嗜酸性粒细胞炎症的Th2淋巴细胞增殖增加。糖皮质激素可抑制上皮细胞中iNOS的诱导,并将升高的呼出气NO降低至正常水平。iNOS的选择性抑制剂未来可能在治疗炎性气道疾病(如哮喘)中发挥作用。

相似文献

1
Nitric oxide and airway disease.一氧化氮与气道疾病
Ann Med. 1995 Jun;27(3):389-93. doi: 10.3109/07853899509002592.
2
Airborne nitric oxide: inflammatory marker and aerocrine messenger in man.空气中的一氧化氮:人类的炎症标志物和气体分泌信使。
Acta Physiol Scand Suppl. 1996;633:1-27.
3
Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid.哮喘患者气道中强效氧化剂过氧亚硝酸盐生成增加与一氧化氮合酶的诱导有关:吸入糖皮质激素的作用。
FASEB J. 1998 Aug;12(11):929-37.
4
Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide.一氧化氮对人培养气道上皮(A549)细胞中诱导型环氧化酶途径的调节
Br J Pharmacol. 1997 Aug;121(7):1482-8. doi: 10.1038/sj.bjp.0701283.
5
Airway nitric oxide output is reduced in bronchiectasis.支气管扩张症患者气道一氧化氮排出量减少。
Respir Med. 2007 Jul;101(7):1549-55. doi: 10.1016/j.rmed.2006.12.005. Epub 2007 Jan 17.
6
Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis.诱导型一氧化氮合酶(iNOS):在哮喘发病机制中的作用
Indian J Biochem Biophys. 2007 Oct;44(5):303-9.
7
Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli.奥拉齐酮可抑制炎症转录因子核因子-κB以及信号转导与转录激活因子1的激活,并减少炎症刺激下诱导型一氧化氮合酶的表达及一氧化氮的产生。
J Pharmacol Exp Ther. 2008 Feb;324(2):858-66. doi: 10.1124/jpet.107.129114. Epub 2007 Nov 26.
8
NO or no NO in asthma?哮喘中的一氧化氮还是无一氧化氮?
Thorax. 1996 Feb;51(2):218-20. doi: 10.1136/thx.51.2.218.
9
[Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].[自由基与抗氧化剂:生理学、人类病理学及治疗学方面(第二部分)]
Therapie. 1998 Jul-Aug;53(4):315-39.
10
[Expression of inducible nitric oxide synthase in asthmatic rat lung].[诱导型一氧化氮合酶在哮喘大鼠肺组织中的表达]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Apr;22(2):186-9.

引用本文的文献

1
Korean Red Ginseng Ameliorates Allergic Asthma through Reduction of Lung Inflammation and Oxidation.韩国红参通过减轻肺部炎症和氧化作用改善过敏性哮喘。
Antioxidants (Basel). 2022 Jul 22;11(8):1422. doi: 10.3390/antiox11081422.
2
Nitric Oxide to Fight Viral Infections.一氧化氮抗击病毒感染。
Adv Sci (Weinh). 2021 Feb 9;8(7):2003895. doi: 10.1002/advs.202003895. eCollection 2021 Apr.
3
Cough reflex sensitivity and fractional exhaled nitric oxide in children with asthma.哮喘患儿的咳嗽反射敏感性和呼出气一氧化氮分数。
Physiol Res. 2020 Dec 31;69(Suppl 3):S455-S461. doi: 10.33549/physiolres.934601.
4
The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond.基于天然矿物质的新型纳米材料IFMC在未摄入的情况下增加血管内一氧化氮:对COVID-19及其他疾病的意义。
Nanomaterials (Basel). 2020 Aug 29;10(9):1699. doi: 10.3390/nano10091699.
5
ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.血管紧张素转换酶2的共同进化模式为新冠疫情中的药物干预提供了靶点。
iScience. 2020 Aug 21;23(8):101384. doi: 10.1016/j.isci.2020.101384. Epub 2020 Jul 18.
6
Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2.SARS-CoV-2 的当前干预措施、诊断方法和纳米技术研究进展的综合综述
Bioconjug Chem. 2020 Sep 16;31(9):2021-2045. doi: 10.1021/acs.bioconjchem.0c00323. Epub 2020 Aug 12.
7
Emergence of novel coronavirus and progress toward treatment and vaccine.新型冠状病毒的出现以及治疗和疫苗的研发进展。
Rev Med Virol. 2020 Jul;30(4):e2116. doi: 10.1002/rmv.2116. Epub 2020 Jun 4.
8
Effect of Humidity on Light-Activated NO and NO Gas Sensing by Hybrid Materials.湿度对混合材料光激活一氧化氮及一氧化氮气体传感的影响
Nanomaterials (Basel). 2020 May 9;10(5):915. doi: 10.3390/nano10050915.
9
Potential interventions for novel coronavirus in China: A systematic review.中国新型冠状病毒潜在干预措施的系统评价。
J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.
10
Modulators of inflammation in Bronchopulmonary Dysplasia.支气管肺发育不良的炎症调节剂。
Semin Perinatol. 2018 Nov;42(7):459-470. doi: 10.1053/j.semperi.2018.09.009. Epub 2018 Oct 2.